‘It’s a straw man argument’: what we heard this week
“We’re not going to get rid of it entirely, overall, so it’s a straw man’s argument that it’s unworkable.” – Deepti Gurdasani, PhD, Queen Mary University, London, on his interpretation of ‘Zero COVID’, aiming for elimination, not eradication.
“It’s amazing and sad, what people will believe,” – Nicole Baldwin, MD, pediatrician and target of attacks by the anti-vaxxer community, discussing a Miami school’s announcement not to allow teachers vaccinated for the sake of “vaccine shedding”. “
“I think we just don’t have enough data at the moment to come to a firm conclusion.” – Al Ozonoff, PhD, Harvard Medical School, discussing cases of facial paralysis after COVID-19 mRNA vaccines.
“While the clinical experience and the anecdotes are encouraging and positive, the data is not there.” – David Mitchell, myeloma survivor and consumer representative on the FDA Oncology Drugs Advisory Committee, explaining his vote against maintaining the fast-track approval status of pembrolizumab (Keytruda) for metastatic urothelial cancer.
“There is a lot of confusion in the community saying if we go out there is no way the virus can affect us.” – Kiran Bhaganagar, PhD, University of Texas at San Antonio, on the science behind the CDC’s updated exterior masking tips.
“I really think there is a lot more work to be done to clean up the supply of hand sanitizer in the United States.” – David Light, CEO of Valisure, whose citizen petition to the FDA likely prompted a recent recall of a hand sanitizer containing benzene.
“I have a firm belief – let me just tell you this – in the marketing departments of all these big pharmaceutical companies to get the word out.” – Richard Pazdur, MD, of the FDA’s Center of Excellence in Oncology, discussing how oncologists would mistakenly think they don’t have immunotherapy options for advanced gastroesophageal cancer if the FDA revokes an approval accelerated for pembrolizumab.
“The problem is, we can’t yet find predictors of good answers.” – Elon Eisenberg, MD, Technion Israel Institute of Technology in Haifa, about the use of cannabis to treat chronic pain.